Daniel Marshall
Senior Manager of Communications and Ownership at Ginkgo
Replay available
Ginkgo Bioworks Holdings Inc (DNA) Q1 2026 Earnings Call
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jason Kelly
Co-founder and CEO
Steve Cohen
CFO
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ginkgo Bioworks Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.942 -- 00:00:05.688 Good evening. I'm Daniel Marshall, Senior Manager of Communications and Ownership at 00:00:05.688 -- 00:00:10.995 Ginkgo. I'm joined by Jason Kelly, our co-founder and CEO, and Steve Cohen, 00:00:10.995 -- 00:00:13.799 our CFO. Thanks, as always, for joining us. 00:00:13.799 -- 00:00:17.343 We're looking forward to updating you on our progress. 00:00:17.343 -- 00:00:22.149 As a reminder, during the presentation today, we will be making forward-looking statements 00:00:22.149 -- 00:00:26.815 which involve risks and uncertainties. Please refer to our filings with the SEC to learn 00:00:26.815 -- 00:00:31.520 more about these risks and uncertainties, including our most recent 10-K. 00:00:31.520 -- 00:00:35.926 Today, in addition to updating you on the quarter results, we're going to provide insight 00:00:35.926 -- 00:00:40.593 into how and why we see autonomous labs like Nebula, our autonomous lab, replacing the 00:00:40.593 -- 00:00:44.979 lab bench, which is where nearly all of biological science is done today. 00:00:44.979 -- 00:00:49.385 As usual, we'll end with a Q&A session, and I'll take questions from analysts, investors, 00:00:49.385 -- 00:00:55.193 and the public. You can submit those questions to us in advance via X, hashtag GinkgoResults, 00:00:55.193 -- 00:00:58.875 or email investors at GinkgoBioworks.com. 00:00:58.898 -- 00:01:01.810 All right, over to you, Jason. 00:01:01.810 -- 00:01:04.274 Thanks, Daniel. We always start with this. 00:01:04.274 -- 00:01:06.498 Gingko's mission is to make biology easier to engineer. 00:01:06.498 -- 00:01:10.966 And I mentioned this at the last earnings call, but in 2026, our focus will be on investing 00:01:10.966 -- 00:01:16.014 to win the category of autonomous labs. And I'm really ...